117 related articles for article (PubMed ID: 28373116)
21. Elevated serum interleukin-38 level at baseline predicts virological response in telbivudine-treated patients with chronic hepatitis B.
Wang HJ; Jiang YF; Wang XR; Zhang ML; Gao PJ
World J Gastroenterol; 2016 May; 22(18):4529-37. PubMed ID: 27182162
[TBL] [Abstract][Full Text] [Related]
22. Protective effect of grape seed extract on gentamicin-induced acute kidney injury.
Safa J; Argani H; Bastani B; Nezami N; Rahimi Ardebili B; Ghorbanihaghjo A; Kalagheichi H; Amirfirouzi A; Mesgari M; Soleimany Rad J
Iran J Kidney Dis; 2010 Oct; 4(4):285-91. PubMed ID: 20852368
[TBL] [Abstract][Full Text] [Related]
23. Telbivudine versus lamivudine and entecavir for treatment-naïve decompensated hepatitis B virus-related cirrhosis.
Yue-Meng W; Li YH; Wu HM; Yang J; Xu Y; Yang LH; Yang JH
Clin Exp Med; 2017 May; 17(2):233-241. PubMed ID: 27094312
[TBL] [Abstract][Full Text] [Related]
24. Tenofovir rescue therapy in pregnant females with chronic hepatitis B.
Hu YH; Liu M; Yi W; Cao YJ; Cai HD
World J Gastroenterol; 2015 Feb; 21(8):2504-9. PubMed ID: 25741161
[TBL] [Abstract][Full Text] [Related]
25. Simvastatin ameliorates gentamicin-induced renal injury in rats.
Jabbari M; Rostami Z; Jenabi A; Bahrami A; Mooraki A
Saudi J Kidney Dis Transpl; 2011 Nov; 22(6):1181-6. PubMed ID: 22089778
[TBL] [Abstract][Full Text] [Related]
26. Cytoprotective effect of vitamin C against gentamicin-induced acute kidney injury in rats.
Stojiljkovic N; Stoiljkovic M; Randjelovic P; Veljkovic S; Mihailovic D
Exp Toxicol Pathol; 2012 Jan; 64(1-2):69-74. PubMed ID: 20619622
[TBL] [Abstract][Full Text] [Related]
27. Telbivudine is associated with improvement of renal function in patients transplanted for HBV liver disease.
Cholongitas E; Vasiliadis T; Goulis I; Fouzas I; Antoniadis N; Papanikolaou V; Akriviadis E
J Viral Hepat; 2015 Jul; 22(7):574-80. PubMed ID: 25385239
[TBL] [Abstract][Full Text] [Related]
28. Protective effect of allicin against gentamicin-induced nephrotoxicity in rats.
El-Kashef DH; El-Kenawi AE; Suddek GM; Salem HA
Int Immunopharmacol; 2015 Dec; 29(2):679-686. PubMed ID: 26391062
[TBL] [Abstract][Full Text] [Related]
29. Efficacy of telbivudine treatment for hepatitis B e antigen-positive chronic hepatitis B patients with poor response to adefovir dipivoxil.
Li Y; Zhang Y; Wang JP; Lian JQ; Bai XF
J Viral Hepat; 2013 Apr; 20 Suppl 1():46-51. PubMed ID: 23458524
[TBL] [Abstract][Full Text] [Related]
30. Protective effects of curcumin on acute gentamicin-induced nephrotoxicity in rats.
He L; Peng X; Zhu J; Liu G; Chen X; Tang C; Liu H; Liu F; Peng Y
Can J Physiol Pharmacol; 2015 Apr; 93(4):275-82. PubMed ID: 25730179
[TBL] [Abstract][Full Text] [Related]
31. Off-treatment efficacy of 3-year nucleos(t)ide analogues in chronic hepatitis B patients.
Lin CC; Bair MJ; Chen CJ; Lee KH; Chen MJ; Liu CY; Chang CW; Hu KC; Liou TC; Lin SC; Wang HY; Chu CH; Shih SC; Wang TE
Kaohsiung J Med Sci; 2016 Jan; 32(1):10-5. PubMed ID: 26853169
[TBL] [Abstract][Full Text] [Related]
32. Changes in serum alanine aminotransferase levels in telbivudine versus lamivudine treatment for chronic hepatitis B: a meta-analysis.
Dai M; Xiao GM; Wang FL; Zhang JS; Li YM; Yang HZ
J Int Med Res; 2015 Apr; 43(2):161-72. PubMed ID: 25687498
[TBL] [Abstract][Full Text] [Related]
33. Evaluation of the protective effect of agmatine against cisplatin nephrotoxicity with 99mTc-DMSA renal scintigraphy and cystatin-C.
Salihoglu YS; Elri T; Gulle K; Can M; Aras M; Ozacmak HS; Cabuk M
Ren Fail; 2016 Oct; 38(9):1496-1502. PubMed ID: 27604130
[TBL] [Abstract][Full Text] [Related]
34. Comparison of renal biomarkers with glomerular filtration rate in susceptibility to the detection of gentamicin-induced acute kidney injury in dogs.
Sasaki A; Sasaki Y; Iwama R; Shimamura S; Yabe K; Takasuna K; Ichijo T; Furuhama K; Satoh H
J Comp Pathol; 2014; 151(2-3):264-70. PubMed ID: 25086870
[TBL] [Abstract][Full Text] [Related]
35. Comparison of the Effects of Telbivudine and Entecavir Treatment on Estimated Glomerular Filtration Rate in Patients with Chronic Hepatitis B.
Lee S; Park JY; Song K; Kim DY; Kim BK; Kim SU; Ku HJ; Han KH; Ahn SH
Gut Liver; 2015 Nov; 9(6):776-83. PubMed ID: 25963085
[TBL] [Abstract][Full Text] [Related]
36. Agmatine improves renal function in gentamicin-induced nephrotoxicity in rats.
El-Kashef DH; El-Kenawi AE; Abdel Rahim M; Suddek GM; Salem HA
Can J Physiol Pharmacol; 2016 Mar; 94(3):278-86. PubMed ID: 26641937
[TBL] [Abstract][Full Text] [Related]
37. Efficacy and safety of telbivudine therapy in liver failure patients with chronic hepatitis B virus infection.
Wang L; Chen H; Fan C; Gong Z
J Med Virol; 2013 Nov; 85(11):1907-12. PubMed ID: 23852947
[TBL] [Abstract][Full Text] [Related]
38. Melatonin synergistically enhances protective effect of atorvastatin against gentamicin-induced nephrotoxicity in rat kidney.
Mehrzadi S; Kamrava SK; Dormanesh B; Motevalian M; Hosseinzadeh A; Hosseini Tabatabaei SM; Ghaznavi H
Can J Physiol Pharmacol; 2016 Mar; 94(3):265-71. PubMed ID: 26762621
[TBL] [Abstract][Full Text] [Related]
39. JBP485 improves gentamicin-induced acute renal failure by regulating the expression and function of Oat1 and Oat3 in rats.
Guo X; Meng Q; Liu Q; Wang C; Sun H; Peng J; Ma X; Kaku T; Liu K
Toxicol Appl Pharmacol; 2013 Sep; 271(2):285-95. PubMed ID: 23707770
[TBL] [Abstract][Full Text] [Related]
40. Protective effect of montelukast which is cysteinyl-leukotriene receptor antagonist on gentamicin-induced nephrotoxicity and oxidative damage in rat kidney.
Otunctemur A; Ozbek E; Cekmen M; Cakir SS; Dursun M; Polat EC; Somay A; Ozbay N
Ren Fail; 2013; 35(3):403-10. PubMed ID: 23342977
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]